More importantly, glucose starvation might affect PD‐L1 expression on cancer cells,[8] while blocking PD‐L1 directly on tumors has been reported to decrease tumor glycolytic metabolism and promote T cell functions.[9] Thus, it should be an exciting and promising strategy to combine glucose starvation with αPD‐L1 therapy. This evidence concerns the gene CD274 and neoplasm.